This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Karakaya, A.E. Articles by Sardas, O.S. Search for Related Content PubMed Articles by Karakaya, A.E. Articles by Sardas, O.S. Social Bookmarking                         What's this?

N-Acetyltransferase Phenotype of Patients with Bladder Cancer

Department of Toxicology, Gazi University, Faculty of Pharmacy

I. Cok

Department of Toxicology, Gazi University, Faculty of Pharmacy

S. Sardas

Department of Toxicology, Gazi University, Faculty of Pharmacy

O. Gögüs

Department of Urology, Ankara University, Faculty of Medicine, Ankara, Turkey

O.S. Sardas

Department of Hematology and Oncology3, Ankara University, Faculty of Medicine, Ankara, Turkey

1 N-Acetyltransferase phenotype has been determined in 109 control subjects and in 23 patients with bladder cancer.

2 Sixty-two per cent of control, and 39% of patients with bladder cancer were phenotypically slow acetylators. This difference was not significant.

3 N-Acetyltransferase phenotype is unlikely to be a major determinant in the development of bladder cancer in the Turkish population.

Human & Experimental Toxicology, Vol. 5, No. 5, 333-335 (1986)
DOI: 10.1177/096032718600500507


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?